Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c × A/J)F1 hybrid hosts

Carmen Gelpi, M. Angeles Martinez, Silvia Vidal, Ana Algueró, Cándido Juarez, John A. Hardin, Jose Luis Rodriguez-Sanchez

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The induction of a chronic graft-versus-host (cGVH) disease in (Balb/c × A/J)F1 mice by the intravenous injection of either Balb/c or A/J parental lymphoid cells led to the development of two different models of disease. In this paper we compared the clinical aspects and the antigen specificities which recognized the autoantibodies developed by the animals of these two models of cGVH disease. Renal disease, alopecia, and purpura lesions were common in both models, although their frequency and intensity varied between groups. The models were differentiated by two main characteristics. When donor cells were of Balb/c origin, a joint disease similar to rheumatoid arthritis developed in 50% of the animals, and when donor cells were of A J origin, 25% of the animals developed edema of the front feet, occasionally with loss of the nails, similar to that of scleroderma. Differences among the autoantibodies found in the sera of these two groups of mice were also observed. After the injection of Balb/c lymphoid cells, rheumatoid factors reactive with human and murine IgG were characteristically present (69 and 75%, respectively) and a statistically significant correlation was found between high titers of rheumatoid factor and arthritis (P < 0.001). Antinuclear antibodies (ANAs) were present in all animals. Anti-dsDNA and anti-histones were positive in 50 and 25%, respectively. Anti-snRNP were detected at a low titer in 35% of the animals. When donor cells were of A J origin, ANAs were also present in all mice. Anti-dsDNA, anti-histones, and anti-snRNPs antibodies were present in 90, 15, and 65%, respectively. The most outstanding characteristics among anti-snRNPs were the high titers of anti-U1 and anti-U3 detected in 50 and 30%, respectively. Rheumatoid factors reactive with human and murine IgG were positive in 15 and 42% of animals, respectively, but no significant correlation was found between these factors and disease. Our results indicate that the graft-versus-host disease induced in the same F1 strain of mice can be manifested in different forms of connective tissue disease, depending on whether the cells come from one or the other of the parental strains. Furthermore, in this paper the occurrence of rheumatoid factors in mice with cGVH is described for the first time.

Original languageEnglish (US)
Pages (from-to)298-310
Number of pages13
JournalClinical Immunology and Immunopathology
Volume56
Issue number3
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Graft vs Host Disease
Rheumatoid Factor
Lymphocytes
Antinuclear Antibodies
Autoantibodies
Histones
Rheumatoid Arthritis
Immunoglobulin G
Small Nuclear Ribonucleoproteins
Connective Tissue Diseases
Purpura
Joint Diseases
Alopecia
Nails
Intravenous Injections
Foot
Anti-Idiotypic Antibodies
Edema
Animal Models
Transplants

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c × A/J)F1 hybrid hosts. / Gelpi, Carmen; Martinez, M. Angeles; Vidal, Silvia; Algueró, Ana; Juarez, Cándido; Hardin, John A.; Rodriguez-Sanchez, Jose Luis.

In: Clinical Immunology and Immunopathology, Vol. 56, No. 3, 1990, p. 298-310.

Research output: Contribution to journalArticle

Gelpi, Carmen ; Martinez, M. Angeles ; Vidal, Silvia ; Algueró, Ana ; Juarez, Cándido ; Hardin, John A. ; Rodriguez-Sanchez, Jose Luis. / Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c × A/J)F1 hybrid hosts. In: Clinical Immunology and Immunopathology. 1990 ; Vol. 56, No. 3. pp. 298-310.
@article{62a901fac24a41f6a9aa7805467ade12,
title = "Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c × A/J)F1 hybrid hosts",
abstract = "The induction of a chronic graft-versus-host (cGVH) disease in (Balb/c × A/J)F1 mice by the intravenous injection of either Balb/c or A/J parental lymphoid cells led to the development of two different models of disease. In this paper we compared the clinical aspects and the antigen specificities which recognized the autoantibodies developed by the animals of these two models of cGVH disease. Renal disease, alopecia, and purpura lesions were common in both models, although their frequency and intensity varied between groups. The models were differentiated by two main characteristics. When donor cells were of Balb/c origin, a joint disease similar to rheumatoid arthritis developed in 50{\%} of the animals, and when donor cells were of A J origin, 25{\%} of the animals developed edema of the front feet, occasionally with loss of the nails, similar to that of scleroderma. Differences among the autoantibodies found in the sera of these two groups of mice were also observed. After the injection of Balb/c lymphoid cells, rheumatoid factors reactive with human and murine IgG were characteristically present (69 and 75{\%}, respectively) and a statistically significant correlation was found between high titers of rheumatoid factor and arthritis (P < 0.001). Antinuclear antibodies (ANAs) were present in all animals. Anti-dsDNA and anti-histones were positive in 50 and 25{\%}, respectively. Anti-snRNP were detected at a low titer in 35{\%} of the animals. When donor cells were of A J origin, ANAs were also present in all mice. Anti-dsDNA, anti-histones, and anti-snRNPs antibodies were present in 90, 15, and 65{\%}, respectively. The most outstanding characteristics among anti-snRNPs were the high titers of anti-U1 and anti-U3 detected in 50 and 30{\%}, respectively. Rheumatoid factors reactive with human and murine IgG were positive in 15 and 42{\%} of animals, respectively, but no significant correlation was found between these factors and disease. Our results indicate that the graft-versus-host disease induced in the same F1 strain of mice can be manifested in different forms of connective tissue disease, depending on whether the cells come from one or the other of the parental strains. Furthermore, in this paper the occurrence of rheumatoid factors in mice with cGVH is described for the first time.",
author = "Carmen Gelpi and Martinez, {M. Angeles} and Silvia Vidal and Ana Alguer{\'o} and C{\'a}ndido Juarez and Hardin, {John A.} and Rodriguez-Sanchez, {Jose Luis}",
year = "1990",
doi = "10.1016/0090-1229(90)90151-F",
language = "English (US)",
volume = "56",
pages = "298--310",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c × A/J)F1 hybrid hosts

AU - Gelpi, Carmen

AU - Martinez, M. Angeles

AU - Vidal, Silvia

AU - Algueró, Ana

AU - Juarez, Cándido

AU - Hardin, John A.

AU - Rodriguez-Sanchez, Jose Luis

PY - 1990

Y1 - 1990

N2 - The induction of a chronic graft-versus-host (cGVH) disease in (Balb/c × A/J)F1 mice by the intravenous injection of either Balb/c or A/J parental lymphoid cells led to the development of two different models of disease. In this paper we compared the clinical aspects and the antigen specificities which recognized the autoantibodies developed by the animals of these two models of cGVH disease. Renal disease, alopecia, and purpura lesions were common in both models, although their frequency and intensity varied between groups. The models were differentiated by two main characteristics. When donor cells were of Balb/c origin, a joint disease similar to rheumatoid arthritis developed in 50% of the animals, and when donor cells were of A J origin, 25% of the animals developed edema of the front feet, occasionally with loss of the nails, similar to that of scleroderma. Differences among the autoantibodies found in the sera of these two groups of mice were also observed. After the injection of Balb/c lymphoid cells, rheumatoid factors reactive with human and murine IgG were characteristically present (69 and 75%, respectively) and a statistically significant correlation was found between high titers of rheumatoid factor and arthritis (P < 0.001). Antinuclear antibodies (ANAs) were present in all animals. Anti-dsDNA and anti-histones were positive in 50 and 25%, respectively. Anti-snRNP were detected at a low titer in 35% of the animals. When donor cells were of A J origin, ANAs were also present in all mice. Anti-dsDNA, anti-histones, and anti-snRNPs antibodies were present in 90, 15, and 65%, respectively. The most outstanding characteristics among anti-snRNPs were the high titers of anti-U1 and anti-U3 detected in 50 and 30%, respectively. Rheumatoid factors reactive with human and murine IgG were positive in 15 and 42% of animals, respectively, but no significant correlation was found between these factors and disease. Our results indicate that the graft-versus-host disease induced in the same F1 strain of mice can be manifested in different forms of connective tissue disease, depending on whether the cells come from one or the other of the parental strains. Furthermore, in this paper the occurrence of rheumatoid factors in mice with cGVH is described for the first time.

AB - The induction of a chronic graft-versus-host (cGVH) disease in (Balb/c × A/J)F1 mice by the intravenous injection of either Balb/c or A/J parental lymphoid cells led to the development of two different models of disease. In this paper we compared the clinical aspects and the antigen specificities which recognized the autoantibodies developed by the animals of these two models of cGVH disease. Renal disease, alopecia, and purpura lesions were common in both models, although their frequency and intensity varied between groups. The models were differentiated by two main characteristics. When donor cells were of Balb/c origin, a joint disease similar to rheumatoid arthritis developed in 50% of the animals, and when donor cells were of A J origin, 25% of the animals developed edema of the front feet, occasionally with loss of the nails, similar to that of scleroderma. Differences among the autoantibodies found in the sera of these two groups of mice were also observed. After the injection of Balb/c lymphoid cells, rheumatoid factors reactive with human and murine IgG were characteristically present (69 and 75%, respectively) and a statistically significant correlation was found between high titers of rheumatoid factor and arthritis (P < 0.001). Antinuclear antibodies (ANAs) were present in all animals. Anti-dsDNA and anti-histones were positive in 50 and 25%, respectively. Anti-snRNP were detected at a low titer in 35% of the animals. When donor cells were of A J origin, ANAs were also present in all mice. Anti-dsDNA, anti-histones, and anti-snRNPs antibodies were present in 90, 15, and 65%, respectively. The most outstanding characteristics among anti-snRNPs were the high titers of anti-U1 and anti-U3 detected in 50 and 30%, respectively. Rheumatoid factors reactive with human and murine IgG were positive in 15 and 42% of animals, respectively, but no significant correlation was found between these factors and disease. Our results indicate that the graft-versus-host disease induced in the same F1 strain of mice can be manifested in different forms of connective tissue disease, depending on whether the cells come from one or the other of the parental strains. Furthermore, in this paper the occurrence of rheumatoid factors in mice with cGVH is described for the first time.

UR - http://www.scopus.com/inward/record.url?scp=0025040431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025040431&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(90)90151-F

DO - 10.1016/0090-1229(90)90151-F

M3 - Article

C2 - 2143968

AN - SCOPUS:0025040431

VL - 56

SP - 298

EP - 310

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -